Recombinant Human Sumo 2 protein
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human Sumo 2 protein is a Human Full Length protein, in the 1 to 93 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE, WB.
View Alternative Names
SMT3B, SMT3H2, SUMO2, Small ubiquitin-related modifier 2, SUMO-2, HSMT3, SMT3 homolog 2, SUMO-3, Sentrin-2, Ubiquitin-like protein SMT3B, Smt3B
- WB
Lab
Western blot - Recombinant Human Sumo 2 protein (AB140420)
**Blocking buffer : ** 5% NFDM/TBST This data was developed using ab109005, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Sumo 2 + Sumo 3 antibody [EPR4602] (<a href='/en-us/products/primary-antibodies/sumo-2-sumo-3-antibody-epr4602-ab109005'>ab109005</a>) at 1/1000 dilution
Lane 1:
Western blot - Recombinant Human Sumo 1 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-1-protein-ab140417'>ab140417</a>) at 0.01 µg
Lane 2:
Western blot - Recombinant Human Sumo 2 protein (ab140420) at 0.01 µg
Lane 3:
Recombinant Human Sumo 3 protein (<a href='/en-us/products/unavailable/recombinant-human-sumo-3-protein-ab140414'>ab140414</a>) at 0.01 µg
Lane 4:
Western blot - Recombinant Human Sumo 4 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-4-protein-ab157025'>ab157025</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 16 kDa
true
Exposure time: 20s
- WB
Lab
Western blot - Recombinant Human Sumo 2 protein (AB140420)
**Blocking buffer : ** 5% NFDM/TBST This data was developed using ab109196, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Sumo 2 + Sumo 3 + Sumo 4 antibody [EPR300(2)] (<a href='/en-us/products/primary-antibodies/sumo-2-sumo-3-sumo-4-antibody-epr3002-ab109196'>ab109196</a>) at 1/200 dilution
Lane 1:
Western blot - Recombinant Human Sumo 1 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-1-protein-ab140417'>ab140417</a>) at 0.01 µg
Lane 2:
Western blot - Recombinant Human Sumo 2 protein (ab140420) at 0.01 µg
Lane 3:
Recombinant Human Sumo 3 protein (<a href='/en-us/products/unavailable/recombinant-human-sumo-3-protein-ab140414'>ab140414</a>) at 0.01 µg
Lane 4:
Western blot - Recombinant Human Sumo 4 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-4-protein-ab157025'>ab157025</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 12 kDa
Observed band size: 16 kDa
true
Exposure time: 20s
- WB
Lab
Western blot - Recombinant Human Sumo 2 protein (AB140420)
**Blocking buffer : ** 5% NFDM/TBST This data was developed using ab133352, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Sumo 1 antibody [EP298] (<a href='/en-us/products/primary-antibodies/sumo-1-antibody-ep298-ab133352'>ab133352</a>) at 1/1000 dilution
Lane 1:
Western blot - Recombinant Human Sumo 1 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-1-protein-ab140417'>ab140417</a>) at 0.01 µg
Lane 2:
Western blot - Recombinant Human Sumo 2 protein (ab140420) at 0.01 µg
Lane 3:
Recombinant Human Sumo 3 protein (<a href='/en-us/products/unavailable/recombinant-human-sumo-3-protein-ab140414'>ab140414</a>) at 0.01 µg
Lane 4:
Western blot - Recombinant Human Sumo 4 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-4-protein-ab157025'>ab157025</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 11 kDa
Observed band size: 16 kDa
true
Exposure time: 10s
- WB
Lab
Western blot - Recombinant Human Sumo 2 protein (AB140420)
**Blocking buffer : ** 5% NFDM/TBST This data was developed using ab126606, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-Sumo 2 + Sumo 3 + Sumo 4 antibody [EPR7163] (<a href='/en-us/products/primary-antibodies/sumo-2-sumo-3-sumo-4-antibody-epr7163-ab126606'>ab126606</a>) at 1/5000 dilution
Lane 1:
Western blot - Recombinant Human Sumo 1 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-1-protein-ab140417'>ab140417</a>) at 0.01 µg
Lane 2:
Western blot - Recombinant Human Sumo 2 protein (ab140420) at 0.01 µg
Lane 3:
Recombinant Human Sumo 3 protein (<a href='/en-us/products/unavailable/recombinant-human-sumo-3-protein-ab140414'>ab140414</a>) at 0.01 µg
Lane 4:
Western blot - Recombinant Human Sumo 4 protein (<a href='/en-us/products/proteins-peptides/recombinant-human-sumo-4-protein-ab157025'>ab157025</a>) at 0.1 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 11 kDa
Observed band size: 16 kDa
true
Exposure time: 3s
- SDS-PAGE
Unknown
SDS-PAGE - Recombinant Human Sumo 2 protein (AB140420)
SDS-PAGE analysis of ab140420.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Sumo 2 influences various cellular processes including nuclear-cytosolic transport transcriptional regulation and protein stability. It often forms part of multi-protein complexes showing versatility in regulating cellular responses to stress and maintaining protein homeostasis. Sumo 2's dynamic attachment and detachment from its target proteins allow fine-tuning of cellular pathways reflecting its essential role in managing cellular conditions.
Pathways
Sumo 2 participates in the DNA damage response and the heat shock response pathways. Its involvement helps ensure proper cell cycle progression and stress response through interaction with key proteins like p53 and HSF1. Sumo 2 modification alters the activity of these proteins and others affecting cell survival under stress conditions and facilitating DNA repair mechanisms showing its comprehensive integration in these important cellular processes.
Specifications
Form
Liquid
General info
Function
Ubiquitin-like protein that can be covalently attached to proteins as a monomer or as a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by an E3 ligase such as PIAS1-4, RANBP2, CBX4 or ZNF451 (PubMed : 26524494). This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Polymeric SUMO2 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins (PubMed : 18408734, PubMed : 18538659, PubMed : 21965678, PubMed : 9556629). Plays a role in the regulation of sumoylation status of SETX (PubMed : 24105744).
Sequence similarities
Belongs to the ubiquitin family. SUMO subfamily.
Post-translational modifications
Polymeric chains can be formed through Lys-11 cross-linking. Polymeric SUMO2 chains undergo 'Lys-6'-, 'Lys-11'-, 'Lys-48'- and 'Lys-63'-linked polyubiquitination by RNF4.. Cleavage of precursor form by SENP1 or SENP2 is necessary for function.. Monoubiquitinated N-terminally by UBE2W, which primes it for RNF4-dependent polyubiquitination by the UBE2V1-UBE2N heterodimer.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com